112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
#2402Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
#2403Cellular cycle anomalies for targeting oncology and neurodegeneration
#2404Gene encoding a DNA repair enzyme and methods of use thereof
#2405TADG-15: an extracellular serine protease overexpressed in carcinomas
#2406Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#2407SCREENING METHOD FOR COMPOUND INHIBITING DEVELOPMENT OR PROGRESSION OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS AND DIAGNOSTIC METHOD FOR FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS
#2408METHODS FOR EVALUATION PROGNOSIS AND FOLLOW-UP OF DRUG TREATMENT OF PSYCHIATRIC DISEASES OR DISORDERS
#2409DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
#2410Marker Genes Based on Amiodarone Treatment for Screening of Drug Inducing Toxicity and Screening Method Therefor
#2411BIOMARKERS FOR GRAFT REJECTION
#2412METHOD OF DIAGNOSING GUM DISEASE-WOUND HEALING USING SINGLE NUCLEOTIDE POLYMORPHISM PROFILES
#2413RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#2414Use of ID4 for diagnosis and treatment of cancer
#2415Method for determining atopic dermatitis using protein marker
#2416Diagnostic Methods and Genetic Markers for Alzheimer Disease
#2417GENES AND POLYPEPTIDES RELATING TO BREAST CANCERS
#2418BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE
#2419Diagnosis and Treatment of Age-Related Macular Degeneration
#2420Methods of determining the prognosis of an adenocarcinoma
#2421Over-expression and mutation of a tyrosine kinase receptor FGFR4 in tumors
#2422METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
#2423Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#2424Biomarkers for Tissue Status
#2425Parkinson's Disease-Related Gene GRK5 and Uses Thereof
#2426Diagnosis of attention deficit hyperactivity disorder
#2427Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
#2428Methods regarding enhanced T-cell receptor-mediated tumor necrosis factor superfamily mRNA expression in peripheral blood leukocytes in patients with crohn's disease
#2429Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
#2430Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
#2431Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
#2432CISD2-Knockout Mice and Uses Thereof
#2433Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402
#2434Modulators of scarb-1 for treating acne or hyperseborrhea
#2435COMPOSITIONS AND METHODS COMPRISING BIOMARKERS OF SPERM QUALITY, SEMEN QUALITY AND FERTILITY
#2436MDA-7 PROTEINS AND METHODS OF USE THEREOF
#2437IDENTIFICATION AND USE OF GPRC VARIANTS IN THE TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE
#2438Methods of Treating Inflammation
#2439Prevention and treatment of osteoarthritis
#2440GENES WHOSE EXPRESSION IS INCREASED IN RESPONSE TO STIMULATION BY CORTICOTROPIN-RELEASING HORMONE
#2441Markers for breast cancer
#2442Lung Cancer Diagnosis Based on Expression Levels of GIMAP Genes
#2443MARKERS FOR BREAST CANCER
#2444Recurrent gene fusions in prostate cancer
#2445Method for the diagnosis and treatment of cardiovascular diseases
#2446FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#2447Markers for diagnosis of pulmonary inflammation and methods related thereto
#2448FIG4 gene mutations in neurodegeneration
#2449Methods of diagnosis and prognosis of pancreatic cancer
#2450Method using snail transcriptional repressor
#2451Cancer biomarker genes and gene products and methods for using the same
#2452Four-jointed box (FJX1) in cancer diagnosis and treatment
#2453Polymorphisms and Haplotypes of the Alpha 2C Adrenergic Receptor Gene
#2454Methods to detect tumors using 20P1F12/TMPRSS2 expression
#2455Gene overexpressed in cancer
#2456DIAGNOSIS AND TREATMENT OF EXOCRINE PANCREATIC DYSFUNCTION AND DIABETES
#2457Methods of identifying and treating individuals exhibiting mutant kit protein
#2458METHOD OF DETECTING AND REDUCING BOAR TAINT USING NUCLEAR RECEPTORS
#2459OCL-2A3 compositions and uses thereof
#2460Cancer Diagnostic Panel
#2461OBESITY AND BODY FAT DISTRIBUTION
#2462METHOD FOR DIAGNOSING HEPATIC DISEASES AND SCREENING METHOD OF MOLECULES FOR TREATMENT OF HEPATIC DISEASE
#2463Simultaneous quantification of nucleic acids in diseased cells
#2464Cancer Related Genes (PRLR)
#2465METHODS TO IDENTIFY FAT AND LEAN ANIMALS USING CLASS PREDICTORS
#2466Novel compositions and methods in cancer
#2467Methods and Compositions for Assessing Alterations in Gene Expression Patterns in Clinically Normal Tissues Obtained from Heterozygous Carriers of Mutant Genes Associated with Cancer and Methods of Use Thereof
#2468Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
#2469Personalizing Cancer Chemotherapy Based on Methylation and Germ-Line Mutational Analysis of BRCA-1
#2470Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases
#2471Novel therapeutic targets in cancer
#2472Novel therapeutic targets in cancer
#2473CACNA1E in Cancer Diagnosis, Detection and Treatment
#2474PRO1120 polypeptides
#2475Diagnosis of anxiety disorders
#2476Compositions and methods for decreasing microrna expression for the treatment of neoplasia
#2477Inhibition of VEGF translation
#2478MARKERS FOR BREAST CANCER
#2479Neurofibromin pathway modulators
#2480Phosphatidylinositol phosphate kinase type I gamma splice variants as biomarkers and drug targets for epithelial cancers
#2481Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#2482Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
#2483Recurrent gene fusions in prostate cancer
#2484Method of diagnosing esophageal cancer
#2485NOVEL USE OF UBIQUITIN C-TERMINAL HYDROLASE-L1
#2486Outcome prediction and risk classification in childhood leukemia
#2487Methods and Kits for Predicting and Monitoring Direct Response to Cancer Therapy
#2488TARGETS IN BREAST CANCER FOR PROGNOSIS OR THERAPY
#2489Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
#2490Secreted protein called 36P6D5 characteristic of tumors
#2491Metabolic Syndrome Genetics
#2492COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION
#2493Gene and polypeptide relating to breast cancer
#2494Methods of Diagnosing and Treating an Inflammatory Response
#2495Translocation and mutant CSF1R Kinase in human leukemia
#2496Methods and compositions for treating diseases targeting CDCP1
#2497Method of treating colorectal carcinoma
#2498Methods for identifying Kremen polypeptide binding partners
#2499Gene overexpressed in cancer
#2500Methods for diagnosis of cardiovascular disease
#2501Imaging, diagnosis and treatment of disease
#2502DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS
#2503Markers for viral infections and other inflammatory responses
#2504Constitutively active fragments of eukaryotic heat shock RNA
#2505CANCER-RELATED NUCLEIC ACIDS
#2506DNA conformation (loop structures) in normal and abnormal gene expression
#2507Markers for metabolic syndrome
#2508Human transcriptomes
#2509IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
#2510Gene Expression Signatures for Oncogenic Pathway Deregulation
#2511Methods and systems for medical sequencing analysis
#2512TRANSCRIPTION FACTOR ARNTL2 GENE AND EXPRESSION PRODUCTS THEREOF USED IN THE DIAGNOSIS, PREVENTION, AND TREATMENT OF TYPE 1 DIABETES
#2513PREDICTIVE AND DIAGNOSTIC METHODS FOR CANCER
#2514Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
#2515Methods for the Treatment of Disease
#2516G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#2517Use of micro-RNA as a biomarker of immunomodulatory drug activity
#2518Lung cancer markers, and uses thereof
#2519Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV
#2520Method of diagnosing bladder cancer
#2521Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
#2522Hunk, a snfi-related kinase essential for mammary tumor metastasis
#2523Screening method of glutathione-increasing substance
#2524Gene Markers and Utilization of the Same
#2525Noxin, a novel stress-induced gene involved in cell cycle and apoptosis
#2526SENP1 as a marker for cancer
#2527Method for diagnosing pancreatic cancer
#2528Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#2529Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
#2530AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2
#2531Low-Density Lipoprotein Receptor-Related Protein 2 Clears Amyloid-Beta Peptide A cross the Blood-Brain Barrier via Apolipoprotein J
#2532Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
#2533ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION
#2534Method for diagnosing methamphetamine dependence
#2535Methods for Assessing the Predisposition or Susceptibility to COPD
#2536RORS as modifiers of the p21 pathway and methods of use
#2537Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction
#2538Strategies for gene expression analysis
#2539JAB1 as a prognostic marker and a therapeutic target for human cancer
#2540BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
#2541IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease
#2542SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#2543Breast cancer related gene ZNFN3A1
#2544Methods of diagnosis and treatment of metabolic disorders
#2545DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE
#2546METHODS FOR TREATING A DISORDER BY REGULATING GPRC6A
#2547Pancreatic cancer targets and uses thereof
#2548Methods, compounds and compositions with genotype selective anticancer activity
#2549Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancer
#2550METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS
#2551METHODS FOR THE TREATMENT, DIAGNOSIS, AND PROGNOSIS OF CANCER
#2552Biomarkers for human papilloma virus-associated cancer
#2553Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
#2554Use of MLN51 gene and protein
#2555Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
#2556N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and Therapy
#2557CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
#2558Complement factor H for diagnosis of age-related macular degeneration
#2559Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
#2560CANCER THERAPY PROGNOSIS AND TARGET
#2561HUMAN PODOCALYXIN ALTERNATIVE-SPLICED FORMS AND USES THEREOF
#2562Methods for determining cancer resistance to histone deacetylase inhibitors
#2563Eubacterial tmRNA sequences and uses thereof
#2564Eubacterial tmRNA sequences and uses thereof
#2565Eubacterial tmRNA sequences and uses thereof
#2566EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
#2567Compositions and methods for diagnosis and treating mood disorders
#2568Identification of TRPML3 (MCOLN3) as a Salty Taste Receptor and Use in Assays for Identifying Taste (Salty) Modulators and/or Therapeutics that Modulate Sodium Transport, Absorption or Excretion and/or Aldosterone and/or Vasopressin Production or Release
#2569Method and kit for diagnosing Autism using gene expression profiling
#2570Breast Endothelial Cell Expression Patterns
#2571DRUG SCREENING AND MOLECULAR DIAGNOSTIC TEST FOR EARLY DETECTION OF COLORECTAL CANCER: REAGENTS, METHODS, AND KITS THEREOF
#2572Method of diagnosing and treating cancer using B-catenin splice variants
#2573Prophylactic/therapeutic agent for cancer
#2574Eubacterial tmRNA sequences and uses thereof
#2575Eubacterial tmRNA sequences and uses thereof
#2576Genetic variant of the annexin A5 gene
#2577SEMA4D in cancer diagnosis, detection and treatment
#2578DLX1 CANCER MARKERS
#2579Modulation of line-1 reverse transcriptase
#2580Methods and kits for investigating cancer
#2581IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
#2582ALPK1 GENE VARIANTS IN DIAGNOSIS RISK OF GOUT
#2583Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives
#2584Methods of identifying anti-cancer agents and uses thereof
#2585Biomarkers and methods for identification of agents useful in the treatment of affective disorders
#2586Markers for melanoma
#2587NECESSARY AND SUFFICIENT REAGENT SETS FOR CHEMOGENOMIC ANALYSIS
#2588COMPOSITIONS AND METHODS FOR TREATING DISEASES
#2589Modulation of transthyretin expression
#2590Method and kit for the determination of cellular activation profiles
#2591Nucleic acids encoding ChemerinR ligands
#2592Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents
#2593METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS
#2594Bone/joint disease sensitivity gene and use thereof
#2595ADRB2 cancer markers
#2596EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
#2597System and method for high resolution analysis of nucleic acids to detect sequence variations
#2598Androgen regulated nucleic acid molecules and encoded proteins
#2599Cancer-suppressing agents
#2600PNMT as a novel marker for progenitor cells
#2601Androgen regulated prostate specific nucleic acids
#2602COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE
#2603USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER
#2604METHODS AND KITS FOR DETECTING MUTATIONS
#2605MAP3Ks as modifiers of the p53 pathway and methods of use
#2606Compositions and methods of treating cancer
#2607Diagnosing and treating hormone resistant cancers
#2608Methods and compositions for detecting colon cancers
#2609Diagnostic and therapeutic targets for leukemia
#2610Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
#2611COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKIN'S LYMPHOMA
#2612PRO1190 polypeptides
#2613Pot1 alternative splicing variants
#2614Reagents and Methods for Modulating Gene Expression Related to Hypertension
#2615Methods for assessing response to therapy in subjects having ulcerative colitis
#2616CONNEXIN 40 TISSUE SPECIFIC GENE MUTATIONS
#2617Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)
#2618Compositions and methods for diagnosing tumors using LEDGF/p75
#2619Gene Marker and Use Thereof
#2620ACACS As Modifiers of the IGF Pathway and Methods of Use
#2621Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase
#2622BIOMARKERS FOR ACUTE GRAFT REJECTION
#2623Effects of inhibitors of FGFR3 on gene transcription
#2624Compositions comprising a ligand of Chemerin R
#2625Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases
#2626Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer
#2627Biomarkers for multiple sclerosis and methods of use thereof
#2628Method of diagnosing cancer and reagents therefor
#2629Detecting disease association with aberrant glycogen synthase kinase 3beta expression
#2630Bone morphogenetic protein antagonist and uses thereof
#2631Modulation of line-1 reverse transcriptase
#2632Use of Novel HNF4a Target Genes and Their Gene Products
#2633Methods for predicting the course of a malignant disease
#2634TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION
#2635METHODS FOR DIAGNOSING AND TREATING BLADDER CANCER
#2636Methods and compositions for treating diseases targeting MABA1
#2637GENETIC VARIANTS ON CHR 15Q24 AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EXFOLIATION SYNDROME AND GLAUCOMA
#2638Identification and use of miRNAs for differentiating myeloid leukemia cells
#2639Compositions and methods for treatment of insulin-resistance diseases
#2640Methods and compositions for the diagnosis and treatment of schizophrenia
#2641Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease
#2642Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight
#2643Chromosome 3p21.3 genes are tumor suppressors
#2644DIAGNOSTICS AND THERAPEUTICS FOR OSTEOPOROSIS
#2645ALDOs as modifiers of the IGF pathway and methods of use
#2646FGF2-RELATED METHODS FOR DIAGNOSING AND TREATING DEPRESSION
#2647Sulfatases and methods of use thereof
#2648Genes involved in neurodegenerative conditions
#2649Stem Cell Markers
#2650METHOD FOR DETECTING ORAL SQUAMOUS-CELL CARCINOMA AND METHOD FOR SUPPRESSING THE SAME
#2651Cancer-suppressing agents
#2652Nucleic acid encoding apolipoprotein E-I3
#2653Methods for the early diagnosis of ovarian cancer
#2654METHOD FOR DETECTING NEUROBLASTOMA AND ITS MALIGNANCY AND METHOD FOR SUPPRESSING THE SAME
#2655Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
#2656Diagnosis and Treatment of Drug Resistant Leukemia
#2657POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE
#2658METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES USING NMDA RECEPTOR GLYCINE SITE ANTAGONISTS
#2659Methods of diagnosing endometriosis
#266014-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type
#2661LARGE DELETIONS IN HUMAN BRCA1 GENE AND USE THEREOF
#2662LARGE DELETIONS IN HUMAN BRCA1 GENE AND USE THEREOF
#2663Method by Using Human or Mice-Isg12 to Develop and Prepare Drugs and Single Nucleotide Polymorphism in the Isg12 Gene for Diagnostic Use
#2664Methods and Kits for Detecting Germ Cell Genomic Instability
#2665Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
#2666Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
#2667Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
#2668Determining Cancer-Linked Genes and Therapeutic Targets Using Molecular Cytogenetic Methods
#2669AMPLIFICATION OF HUMAN MDM2 GENE IN HUMAN TUMORS
#2670Alpha-Synuclein Kinase
#2671Detection and Treatment of Fibrotic Disorders
#2672Novel therapeutic targets in cancer
#2673Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
#2674Genetic basis of treatment response in depression patients
#2675Cancer Treatment Resistance and Agents Modulating Such Resistance
#2676Polynucleotides and Polypeptides of the IFNalpha-21 Gene
#2677ISOLATION AND GROWTH OF STEM CELLS FROM HEMANGIOMAS
#2678Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
#2679METHOD FOR TREATING CHRONIC LYMPHOID LEUKEMIA
#2680Markers and Methods for Assessing and Treating Ulcerative Colitis and Related Disorders Using a 43 Gene Panel
#2681Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profiling
#2682METHODS AND KITS BASED ON UGT1A7 PROMOTER POLYMORPHISM
#2683COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
#2684Method for the analysis of differential expression in colorectal cancer
#2685Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereof
#2686Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
#2687Compositions and methods for the identification, assessment, prevention and therapy of human cancers
#2688Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas
#2689Methods and compositions for the diagnosis and treatment of ewing's sarcoma
#2690Compositions and methods for treating vascular permeability
#2691SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTASIS
#2692IN VITRO METHODS FOR DETECTING RENAL CANCER
#2693Kinases and uses thereof
#2694Novel Therapeutic Targets in Cancer
#2695Use Of Genes As Molecular Markers In Diagnosis Of Schizophrenia And Diagnostic Kit For The Same
#2696Imaging, diagnosis and treatment of disease
#2697Model system for identifying anti-cancer agents
#2698Soluble ErbB3 and treatment of cancer
#2699Methods of controlling bone loss by inhibiting DKK1
#2700Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer